Genentech's Plan To Restrict Avastin Under Scrutiny
A U.S. senator is investigating Genentech Inc.'s proposed plan to limit the availability of its cancer drug Avastin to certain pharmaceutical compounding firms and pharmacies....To view the full article, register now.
Already a subscriber? Click here to view full article